Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H&R GmbH KGaA (WBO:2HRA) Total Current Assets Explanation
In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.
H&R GmbH KGaA's Liquidation Value for the quarter that ended in Mar. 2026 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H&R GmbH KGaA Total Current Assets Related Terms
H&R GmbH KGaA Total Current Assets Historical Data
* Premium members only.
The historical data trend for H&R GmbH KGaA's Total Current Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.
What does a Total Current Assets of €420 Mil mean?
H&R GmbH KGaA (WBO:2HRA) has a Total Current Assets of €420 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for H&R GmbH KGaA and its competitors.
Is H&R GmbH KGaA's Total Current Assets too high?
H&R GmbH KGaA's current Total Current Assets is €420 Mil. Overall, H&R GmbH KGaA has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H&R GmbH KGaA's Total Current Assets compare to LIN and SHW?
H&R GmbH KGaA's Total Current Assets of €420 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Assets for a Chemicals company?
A good Total Current Assets depends on the Chemicals industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Assets mean?
A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for H&R GmbH KGaA and its competitors. H&R GmbH KGaA's current Total Current Assets is €420 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H&R GmbH KGaA stock overvalued right now?
Based on GuruFocus' analysis, H&R GmbH KGaA (WBO:2HRA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.25, compared to a current price of €6.46 — trading 52% above its estimated fair value. The current Total Current Assets is €420 Mil. H&R GmbH KGaA's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Assets calculated?
Total Current Assets is calculated from a company's financial statements. For H&R GmbH KGaA (WBO:2HRA), the current Total Current Assets is €420 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H&R GmbH KGaA (WBO:2HRA) Overvalued in 2026?
Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued.
The current stock price of €6.46 is trading 52% above its estimated GF Value™ of €4.25.
GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.
Key valuation signals for WBO:2HRA:
Total Current Assets: €420 Mil
GF Value™: €4.25 vs. price of €6.46 (52% above fair value)
No single metric tells the full story. See the WBO:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
40GF Score
Get the complete analysis for WBO:2HRA
Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:2HRA has been successfully added to your 
